SCHEMBL9507549

SCHEMBL9507549

FC(F)(F)c1ccc(Oc2ccccc2)nc1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.64
KMT2A Q03164 1/20 0.62
LIPE Q05469 8/20 0.60
MAPT P10636 3/20 0.60
NPSR1 Q6W5P4 2/20 0.60
HPGD P15428 1/20 0.59
LMNA P02545 1/20 0.58
RAB9A P51151 1/20 0.58
THRB P10828 1/20 0.57
SMN1; SMN2 Q16637 2/20 0.56
TSHR P16473 1/20 0.56
CYP3A4 P08684 1/20 0.55
GAA P10253 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55
HTT P42858 1/20 0.55
POLB P06746 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.54
BCHE P06276 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11351938 0.91 MAPT (0.69) MAPK1KMT2ALIPEMAPTNPSR1
SCHEMBL4728325 0.83 KDM4E (0.62) MAPK1KMT2ALIPEMAPTNPSR1
SCHEMBL21652204 0.83 RAB9A (0.67) MAPK1KMT2ALIPEMAPTNPSR1
SCHEMBL30690168 0.83 LMNA (0.63) MAPK1KMT2ALIPEMAPTNPSR1
SCHEMBL906222 0.83 LMNA (0.63) MAPK1KMT2ALIPEMAPTNPSR1
SCHEMBL921136 0.83 MAPT (0.57) MAPK1KMT2ALIPEMAPTNPSR1
SCHEMBL8576331 0.83 MAPT (0.65) MAPK1KMT2ALIPEMAPTNPSR1
SCHEMBL11391846 0.83 LIPE (0.67) MAPK1LIPEMAPTNPSR1HPGD
SCHEMBL9272113 0.83 THRB (0.76) MAPK1KMT2ALIPEMAPTNPSR1
SCHEMBL11383589 0.83 LIPE (0.65) MAPK1KMT2ALIPEMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4152328-A 2-PHENOXY-5-TRIFLUOROMETHYLPYRIDINE COMPOUNDS AND PROCESS FOR PREPARATION THEREOF ISHIHARA SANGYO KAISHA LTD. (JP) 1979-05-01 US claimed
JP-61280476-A None JP disclosed
US-20240024313-A1 BIARYL ETHER UREA COMPOUNDS Jazz Pharmaceuticals Therapeutics, Inc. 2024-01-25 US disclosed
US-20200172518-A1 SULFONAMIDE-SUBSTITUTED CYANOPYRROLIDINES WITH ACTIVITY AS DUB INHIBITORS MISSION THERAPEUTICS LIMITED (GB) 2020-06-04 US disclosed
WO-2018210660-A1 HETEROARYL COMPOUNDS AS AGROCHEMICAL FUNGICIDES BASF SE (DE) 2018-11-22 WO disclosed
WO-2018210658-A1 HETEROARYL COMPOUNDS AS AGROCHEMICAL FUNGICIDES BASF SE (DE) 2018-11-22 WO disclosed
WO-2018210661-A1 HETEROARYL COMPOUNDS AS AGROCHEMICAL FUNGICIDES BASF SE (DE) 2018-11-22 WO disclosed
WO-2018210659-A1 HETEROARYL COMPOUNDS AS AGROCHEMICAL FUNGICIDES BASF SE (DE) 2018-11-22 WO disclosed
EP-0281103-B1 PHENOXYCARBOXYLIC ACID COMPOUNDS AND HERBICIDE COMPRISING IT AS ACTIVE INGREDIENT TEIJIN LIMITED (JP) 1993-06-23 EP disclosed
US-4845264-A PRE- AND POST-EMERGENCE FOR BROAD-LEAVED WEEDS TEIJIN LIMITED (JP) 1989-07-04 US disclosed
EP-0281103-A2 Phenoxycarboxylic acid compounds and herbicide comprising it as active ingredient TEIJIN LIMITED (JP) 1988-09-07 EP disclosed
JP-S61280476-A 2-PHENOXY-5-TRIFLUOROMETHYLPYRIDINE COMPOUND ISHIHARA SANGYO KAISHA LTD 1986-12-11 JP disclosed
US-4267336-A BY REACTING A 2-PHENOXYPYRIDINE DERIVATIVE WITH A 4-HYDROXYPHENOXYALKANECARBOXYLIC ACID DERIVATIVE ISHIHARA SANGYO KAISHA LTD. (JP) 1981-05-12 US disclosed
US-4152328-A 2-PHENOXY-5-TRIFLUOROMETHYLPYRIDINE COMPOUNDS AND PROCESS FOR PREPARATION THEREOF ISHIHARA SANGYO KAISHA LTD. (JP) 1979-05-01 US disclosed
US-4152328-A 2-PHENOXY-5-TRIFLUOROMETHYLPYRIDINE COMPOUNDS AND PROCESS FOR PREPARATION THEREOF ISHIHARA SANGYO KAISHA LTD. (JP) 1979-05-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200172518-A1 SULFONAMIDE-SUBSTITUTED CYANOPYRROLIDINES WITH ACTIVITY AS DUB INHIBITORS USP30, USP1, USP39 MAPK1 2003/4885KMT2A 2752/4885LIPE 3297/4885
US-20240024313-A1 BIARYL ETHER UREA COMPOUNDS FAAH, FAAH2, FAH MAPK1 4121/4885KMT2A 1992/4885LIPE 25/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.